Loading clinical trials...
Loading clinical trials...
Myeloproliferative disorders (MPD) include chronic myeloid leukemia (CML) (Ph +) and essential thrombocythemia (ET), the polycythemia vera (PV), myelofibrosis (MF) called SMP Ph. CML is the ultimate m...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Collaborators
NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more
NCT07445984 · Chronic Leukemia, Acute Leukemia, and more
NCT06315309 · GVHD,Acute, Acute Leukemia, and more
NCT00935090 · Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, and more
NCT01137825 · Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, and more
CHU de Nice
Nice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions